Rupert Hill is Global Head of Pharmaceuticals and Head of European Healthcare at the Investment Bank Greenhill.
Rupert joined Greenhill in 2012 and has over 20 years of healthcare investment banking experience. Prior to joining Greenhill, he was the Head of Healthcare for EMEA and Asia Pacific at Bank of America Merrill Lynch, having originally joined Merrill Lynch in 2000.
Prior to his time at Merrill Lynch, Rupert worked at Charterhouse Bank, having qualified as a Chartered Accountant with Price Waterhouse in London and Paris. He speaks fluent French and Spanish.